ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,643Medicare Part D Prescriptions Filled, Including Refills

Rank: 48 out of 262

$418K Total Retail Price of All Prescriptions

Rank: 46 out of 262

454 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 454 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 454 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 4,919 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
LEVOTHYROXINE SODIUM 389 238 1 2
SIMVASTATIN 375 313 2 1
LISINOPRIL 327 255 3 3
OMEPRAZOLE 271 139 4 5
HYDROCHLOROTHIAZIDE 264 214 5 7
AMLODIPINE BESYLATE 232 186 6 6
METFORMIN HCL 207 155 7 9
PRAVASTATIN SODIUM 202 152 8 41
METOPROLOL TARTRATE 200 167 9 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 149 115 10 24
HYDROCODONE-ACETAMINOPHEN 146 66 S3 11 15
ATORVASTATIN CALCIUM 146 115 11 13
TRAMADOL HCL 145 49 13 18
METOPROLOL SUCCINATE 130 112 14 11
FENOFIBRATE 118 24 15 77
FUROSEMIDE 109 86 16 4
CITALOPRAM HBR 103 62 17 20
FLUTICASONE PROPIONATE 99 67 18 48
ATENOLOL 90 62 19 16
GABAPENTIN 89 49 20 19
ADVAIR DISKUS 81 36 21 34
LOSARTAN POTASSIUM 79 66 22 17
TAMSULOSIN HCL 77 43 23 25
SERTRALINE HCL 76 37 24 14
ZETIA 76 69 24 60
FLUOXETINE HCL 63 28 26 46
DOXAZOSIN MESYLATE 63 61 26 59
ZOLPIDEM TARTRATE 61 35 28 26
WARFARIN SODIUM 61 46 28 12
GEMFIBROZIL 60 35 30 92
LOSARTAN-HYDROCHLOROTHIAZIDE 57 43 31 43
CARVEDILOL 57 42 31 31
NEXIUM 57 41 31 57
POLYETHYLENE GLYCOL 3350 54 18 34 42
GLIPIZIDE XL 53 44 35 87
TRIAMTERENE-HCTZ 52 43 36 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 21, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.